Lunai Bioworks (LNAI) Shares Outstanding (Diluted Average) (2022 - 2026)

Lunai Bioworks' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $23.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 44.83% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $23.7 million (up 44.83% YoY), while the FY2025 annual figure was $165.1 million, up 69.27% from the prior year.
• Shares Outstanding (Diluted Average) was $23.7 million for Q1 2026 at Lunai Bioworks, up from $23.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $165.1 million in Q2 2025 to a low of $16.0 million in Q3 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $54.1 million across 5 years, with a median of $55.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) soared 73.31% in 2024, then plunged 79.45% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $55.5 million in 2022, then rose by 17.4% to $65.2 million in 2023, then sank by 75.17% to $16.2 million in 2024, then surged by 45.11% to $23.5 million in 2025, then advanced by 1.11% to $23.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $23.7 million (Q1 2026), $23.5 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.